A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: HER2-positive Breast Cancer|HER2-low Breast Cancer|Breast Cancer|Advanced Cancer
Interventions: DRUG: Trastuzumab deruxtecan
Sponsor: Daiichi Sankyo